View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/jazz-pharmaceuticals-to-report-second-quarter-financial-results-on-august-3-2026-302829880.html

© 2026 PR Newswire
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 213,20 | 218,60 | 09:11 | |
| 213,20 | 218,40 | 09:11 |
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/jazz-pharmaceuticals-to-report-second-quarter-financial-results-on-august-3-2026-302829880.html

| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Jazz Pharmaceuticals plc: Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026 | View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/jazz-pharmaceuticals-to-report-second-quarter-financial-results-on-august-3-2026-302829880... ► Artikel lesen | |
| 23.06. | Jazz Pharmaceuticals' Lung Cancer Drug Setback in Late-Stage Trials: Here's Why the Stock Impact May Be More Limited Than It Looks | ||
| 17.06. | Jazz Pharmaceuticals Gains Oncology Firepower Through AbCellera Collaboration | ||
| 17.06. | Jazz Pharma, AbCellera Collaborate on Next-Gen T-Cell Engaging Antibody Discovery | ||
| 17.06. | AbCellera Biologics Inc.: Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies | The collaboration includes $56 million in upfront payments to AbCellera and up to $792 million in potential option fees and milestone payments for any program Jazz exercises its option to develop... ► Artikel lesen |